These in vivo and in vitro ROCK1 knockdown data confirmed that reduced ROCK1 signaling inhibits the recruitment and differentiation of LepR+ cells in prostatic hyperplasia. The gene discussed is LEPR; the disease is benign prostatic hyperplasia.